Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05159596 · ClinicalTrials.gov registry record · NA

In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by University of California, Berkeley.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT05159596: Completed NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by University of California, Berkeley.

NCT05159596 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that has completed, run by University of California, Berkeley. The registered enrollment target is 6 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05159596, a NA study of Alzheimer Disease and Mild Cognitive Impairment, has completed, sponsored by University of California, Berkeley.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

Primary Outcome

Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.

Conditions Studied

Alzheimer Disease Mild Cognitive Impairment Dementia

Interventions

  • DEVICE In-Home Technology System
  • DEVICE Limited In-Home Technology

Study Locations (1)

California

  • University of California, Berkeley - Berkeley

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2022-09-20
Est. Completion 2023-10-30
Phase NA
University of California, Berkeley

72 total trials

What the finished NCT05159596 record still lists

NCT05159596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (100% lower).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which In-Home Technology System is the first listed.

NCT05159596 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05159596 about?

NCT05159596 is a clinical study titled "In-Home Technology for Caregivers of People With Dementia and Mild Cognitive Impairment: Spanish Language Homes". This study aims to develop, evaluate, and commercialize an in-home supportive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease, other dementias, or mild cognitive impairment in Spanish language homes.

What is the current status of trial NCT05159596?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2022-09-20. Estimated completion is 2023-10-30.

What conditions does trial NCT05159596 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Dementia.

What interventions are being tested in trial NCT05159596?

The interventions under investigation include: In-Home Technology System (DEVICE), Limited In-Home Technology (DEVICE).

Who is sponsoring clinical trial NCT05159596?

This trial is sponsored by University of California, Berkeley, which has 72 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05159596 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05159596's enrollment target sits among peer trials

6 300th of 306 higher than 5 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT05159596, the US trial registry maintained by the National Library of Medicine. NCT05159596 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.